Brief: Suven Life Sciences Says March-Quarter Consol Net Loss Narrows
04/05/2021 09:47
May 4 (Reuters) - Suven Life Sciences Ltd SUVP.NS :
* SUVEN LIFE SCIENCES LTD MARCH-QUARTER CONSOL NET LOSS 216.1 MILLION RUPEES VERSUS LOSS
255.6
MILLION RUPEES YEAR AGO
Source text for Eikon: ID:nBSE2tVj7x
Further company coverage: SUVP.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Suven Life Sciences
See all newsBrief: Suven Life Sciences Completes Patient Enrollment In Global Phase-3 Masupirdine Study
India's Suven Life Sciences gains after Masupirdine Phase-3 study completes patient enrollment
Brief: Suven Life Sciences Completes Phase-1 Study Of SUVN-I6107, Advances To Phase-2
Brief: Suven Life Sciences Reports Positive DSMB Safety Review For Phase-3 Masupirdine Study
Brief: Suven Life Sciences Records 100% Patient Enrolment Milestone In Phase-2B Clinical Trial Of Ropanicant